Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This session will explore the latest innovations in organoid culture techniques and their applications in cancer research. Emphasis will be placed on the development of organoid models that accurately recapitulate tumor microenvironments.
This track focuses on the role of organoids in the identification and testing of novel therapeutic agents. Participants will discuss case studies demonstrating the predictive power of organoid models in drug response.
This session will delve into the derivation of organoids from stem cells and their potential in regenerative medicine. Discussions will highlight the implications for personalized treatment strategies in cancer.
Participants will present research utilizing organoids to model various cancer types and their underlying biological mechanisms. The focus will be on how these models can elucidate disease progression and inform therapeutic strategies.
This track will examine the integration of organoid technology into precision medicine frameworks. Discussions will center on tailoring cancer treatments based on individual organoid responses.
This session will investigate the intersection of tissue engineering and organoid research. Key topics will include the development of hybrid systems that enhance organoid functionality and viability.
This track will focus on the translation of organoid research into clinical settings. Participants will share insights on how organoid models are being utilized in patient-specific treatment planning.
This session will address the ethical implications surrounding the use of organoids in research and medicine. Discussions will include consent, ownership, and the potential for commercialization.
This track will explore the role of organoids in studying the immune response to cancer therapies. Participants will discuss how organoid models can aid in the development of immunotherapeutic strategies.
This session will highlight cutting-edge technologies that are enhancing organoid research, including CRISPR and single-cell sequencing. The focus will be on how these tools are advancing our understanding of cancer biology.
This track will emphasize the importance of interdisciplinary collaboration in advancing organoid research. Participants will share successful partnerships between academia, industry, and clinical institutions.